BRIACELL THERAP Operating Income Growth

Operating Income Growth of BCTX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Income Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Operating Income Growth for the quarter ending October 31, 2022 was -136.48% (a -16.94% decrease compared to previous quarter)
  • Year-over-year quarterly Operating Income Growth decreased by -93.07%
  • Annual Operating Income Growth for 2022 was -119.16% (a 54.59% increase from previous year)
  • Annual Operating Income Growth for 2021 was -77.08% (a -576.1% decrease from previous year)
  • Annual Operating Income Growth for 2020 was 16.19% (a -179.91% decrease from previous year)
  • Twelve month Operating Income Growth ending October 31, 2022 was -107.28% (a -9.97% decrease compared to previous quarter)
  • Twelve month trailing Operating Income Growth decreased by -80.82% year-over-year
Trailing Operating Income Growth for the last four month:
31 Oct '22 31 Jul '22 30 Apr '22 31 Jan '22
-107.28% -119.16% -103.72% -559.36%
Visit stockrow.com/BCTX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Income Growth of BRIACELL THERAP

Most recent Operating Income Growthof BCTX including historical data for past 10 years.

Interactive Chart of Operating Income Growth of BRIACELL THERAP

BRIACELL THERAP Operating Income Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -136.48% -164.31% -0.81% -1968.6% -119.16%
2021 -500.63% -90.8% -850.13% 86.69% -77.08%
2020 67.42% 28.45% 55.11% -0.87% 16.19%
2019 -18.36% 21.87% -1.24% -80.11% -20.26%
2018 -92.58% -70.46% -26.34% -137.43% -61.28%
2017 -55.29% -75.7% -235.95% 50.28% -47.66%
2016 -72.54% -265.33% 29.39% 67.64% 37.08%
2015 -245.75% 20.21% -275.63% -2289.31% -488.25%
2014 32.15% -72.91% 16.19% 21.66% -2.52%
2013 24.19% 32.45% -5.64% 21.61% 21.12%
2012 29.32% 70.83% 52.43% 45.86%

Business Profile of BRIACELL THERAP

Sector: Healthcare
Industry: Biotechnology